Last reviewed · How we verify

Prevention of Perioperative Infection — Treatment Landscape & Competitive Intelligence

Prevention of Perioperative Infection (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Prevention of Perioperative Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Rocephin ceftriaxone Generic (originally Roche) Cephalosporin antibiotic (third-generation) Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A 1984-12-21
Zinacef CEFUROXIME GSK Cephalosporin Antibacterial Carbonic anhydrase 2 1983-01-01
Claforan CEFOTAXIME Sterimax Cephalosporin Antibacterial 1981-01-01
Cefradex cefradine Bristol-Myers Squibb cefradine Matrix metalloproteinase-9 1974-01-01
Cefaprin cefapirin Bristol-Myers Squibb cefapirin Sigma non-opioid intracellular receptor 1 1974-01-01
Cephalotin cefalotin Eli Lilly cefalotin Solute carrier family 22 member 8 1974-01-01
Ancef In Sodium Chloride 0.9% In Plastic Container CEFAZOLIN GSK Cephalosporin Antibacterial 1973-01-01
Ancef In Sodium Chloride 0.9% In Plastic Container Cefazolin Sodium GSK Cephalosporin Bacterial cell wall peptidoglycan 1973-01-01
Metro I.V. In Plastic Container METRONIDAZOLE Baxter Nitroimidazole Antimicrobial [EPC] 1963-01-01
Ceftriaxon Ceftriaxon Centre Hospitalier Universitaire Vaudois Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 6 drugs in Prevention of Perioperative Infection
  2. GSK · 3 drugs in Prevention of Perioperative Infection
  3. Bristol-Myers Squibb · 2 drugs in Prevention of Perioperative Infection
  4. Eli Lilly · 1 drug in Prevention of Perioperative Infection
  5. Generic (originally Roche) · 1 drug in Prevention of Perioperative Infection
  6. HaEmek Medical Center, Israel · 1 drug in Prevention of Perioperative Infection
  7. Nantes University Hospital · 1 drug in Prevention of Perioperative Infection
  8. Sohag University · 1 drug in Prevention of Perioperative Infection
  9. Sterimax · 1 drug in Prevention of Perioperative Infection
  10. University of Oslo · 1 drug in Prevention of Perioperative Infection
  11. Baxter · 1 drug in Prevention of Perioperative Infection
  12. Centre Hospitalier Universitaire Vaudois · 1 drug in Prevention of Perioperative Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Prevention of Perioperative Infection:

Cite this brief

Drug Landscape (2026). Prevention of Perioperative Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-perioperative-infection. Accessed 2026-06-11.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing